These results may help guide management strategies and prognostication among patients with advanced NSCLC who experience severe irAE and in whom permanent ICI discontinuation is required,” the ...

The United States is now experiencing its largest measles outbreak since the disease was declared eliminated in 2000.

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

(HealthDay News) — The US Department of Health and Human Services (HHS) and US Food and Drug Administration (FDA) recently announced a plan to remove all petroleum-based synthetic dyes from the nation ...

The primary endpoint was the mean normalcy of diet score on the clinician-rated Performance Status Scale for Head and Neck at 1 year. The mean score was 91.6 in the dose-reduction arm and 92.6 in the ...

The Trump administration has replaced two major federal websites for COVID information with a new page that promotes the theory that SARS-CoV-2 came from a lab in China.

We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited cont ...

Data suggest that taletrectinib “provides clinically meaningful tumor shrinkage and prolonged disease control as a treatment option for advanced ROS1+ NSCLC, regardless of treatment history,” ...

The DOJ has sent letters to CHEST and other journals asking that editors answer questions about bias and misinformation.

The combination of toripalimab, nimotuzumab, and chemotherapy showed “promising antitumor activity with acceptable toxicity,” researchers wrote.

CAR T-cell therapy showed encouraging efficacy and good safety in newly diagnosed Ph-positive ALL,” the researchers wrote.

This move is the latest in a series of attempts by the Trump administration to eliminate DEI/DEIA programs and reduce NIH funding.